Drug profile · INN
daunorubicin citrate
DAUNOXOME
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
daunorubicin citrate (DAUNOXOME) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN daunorubicin citrate
Brand DAUNOXOME
Route INJECTION
Formulation INJECTABLE, LIPOSOMAL
Frequently asked questions
What is daunorubicin citrate?
daunorubicin citrate (DAUNOXOME) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for daunorubicin citrate?
DAUNOXOME is a marketed brand name for daunorubicin citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of daunorubicin citrate?
daunorubicin citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.